| CKD (n = 110) | Healthy controls (n = 55) | P-value |
---|---|---|---|
Age, years | 61 ± 12 | 64 ± 11 | 0.038 |
Men (%) | 75 (68) | 31 (56) | n.s. |
Body weight, kg | 83 ± 16 | 75 ± 14 | 0.002 |
BMI, kg/m2 | 27.0 ± 3.8 | 25.1 ± 3.3 | 0.001 |
Current or former smoker (%) | 55 (50) | 14 [26] | 0.003 |
Hypertension (%) | 96 (87) | 0 | <0.001 |
Diabetes (%) | 31 (28) | 0 | <0.001 |
Atherosclerotic CV disease (%) | 16 (15) | 0 | 0.001 |
Ambulatory SBP, mmHg | 124 ± 15 | 120 ± 12 | n.s. |
Ambulatory DBP, mmHg | 73 ± 10 | 72 ± 7 | n.s. |
Carotid-femoral PWV, m/s | 9.6 ± 2.7 | 8.7 ± 2.0 | n.s. |
mGFR, ml/min/1.73 m2 | 36 ± 15 | 85 ± 13 | <0.001 |
S-creatinine, µmol/L | 184 ± 72 | 76 ± 12 | <0.001 |
S-cystatin c, mg/L | 2.00 ± 0.66 | 0.92 ± 0.14 | <0.001 |
U-ACR, mg/mmol | 15 (3–73) | 0 (0.0–0.4) | <0.001 |
B-Hemoglobin, g/L | 127 ± 14 | 136 ± 11 | <0.001 |
S-hsCRP, mg/L | 3.25 ± 4.04 | 1.44 ± 2.03 | <0.001 |
P-ApoB/ApoA1 | 0.75 ± 0.28 | 0.66 ± 0.17 | 0.030 |
S-phosphate, mmol/L | 1.11 ± 0.23 | 1.02 ± 0.15 | n.s. |
S-PTH, pmol/L | 10.9 ± 8.1 | 5.4 ± 1.7 | <0.001 |
S-FGF-23, ng/L | 185 ± 165 | 69 ± 19 | <0.001 |
S-TnT, ng/L | 13.1 (8.0–19.0) | 5.7 (0.0–9.4) | <0.001 |
S-NTpro-BNP, ng/L | 151 (78–285) | 55 (33–98) | <0.001 |